These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37698412)

  • 1. Daily fosfomycin versus levofloxacin for complicated urinary tract infections.
    Rouphael N; Winokur P; Keefer MC; Traenkner J; Drobeniuc A; Doi Y; Munsiff S; Fowler VG; Evans S; Oler RE; Tuyishimire B; Lee M; Ghazaryan V; Chambers HF;
    mBio; 2023 Oct; 14(5):e0167723. PubMed ID: 37698412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of 2 days of treatment by fosfomycin calcium for acute uncomplicated cystitis in women.
    Matsumoto T; Muratani T; Nakahama C; Tomono K
    J Infect Chemother; 2011 Feb; 17(1):80-6. PubMed ID: 20694571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience of using the antibacterial drug Fosfomycin Esparma for the treatment of acute uncomplicated cystitis in women].
    Aboyan IA; Orlov YN; Voloshina OA; Orlov NV; Pavlov DS
    Urologiia; 2019 Sep; (4):20-25. PubMed ID: 31535800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fosfomycin-trometamol for Urinary Tract Infections in Kidney Transplant Recipients.
    Ten Doesschate T; van Werkhoven H; Meijvis S; Stalenhoef J; van Zuilen A; de Vries A; Bonten M
    Transplantation; 2019 Jun; 103(6):1272-1276. PubMed ID: 30130327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study.
    Koguchi D; Murakami Y; Ikeda M; Dobashi M; Ishii J
    BMC Urol; 2020 Apr; 20(1):38. PubMed ID: 32252747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of fosfomycin in the management of urinary tract infections].
    Zaitsev AV; Kolontarev KB
    Urologiia; 2017 Sep; (4):91-96. PubMed ID: 28952700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fosfomycin Trometamol versus Comparator Antibiotics for the Treatment of Acute Uncomplicated Urinary Tract Infections in Women: A Systematic Review and Meta-Analysis.
    Cai T; Tamanini I; Tascini C; Köves B; Bonkat G; Gacci M; Novelli A; Horcajada JP; Bjerklund Johansen TE; Zanel G
    J Urol; 2020 Mar; 203(3):570-578. PubMed ID: 31651226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, active-controlled, multicentre clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus levofloxacin in Chinese adults with acute uncomplicated or complicated urinary tract infection.
    Li Y; Yin Y; Peng X; Zheng H; Fu F; Liu Z; Wu X; Wu X; Zheng S; Chen N; He L; Ren L; Ni Z; Li D; Liang P; Lv X; Zhang Y
    Ann Med; 2021 Dec; 53(1):217-226. PubMed ID: 33331182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection].
    Kuzmenko AV; Kuzmenko VV; Gyaurgiev TA
    Urologiia; 2019 Dec; (6):38-43. PubMed ID: 32003165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol.
    Cai T; Verze P; Arcaniolo D; Pandolfo SD; Smarrazzo F; Manfredi C; Tascini C; Caciagli P; Lanzafame M; De Sio M; Wagenlehner F; Johansen TEB; Palmieri A
    Int J Antimicrob Agents; 2023 Nov; 62(5):106974. PubMed ID: 37739241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients-Results of a Spanish multicenter cohort.
    López-Medrano F; Silva JT; Fernández-Ruiz M; Vidal E; Origüen J; Calvo-Cano A; Luna-Huerta E; Merino E; Hernández D; Jironda-Gallegos C; Escudero R; Gioia F; Moreno A; Roca C; Cordero E; Janeiro D; Sánchez-Sobrino B; Montero MM; Redondo D; Candel FJ; Pérez-Flores I; Armiñanzas C; González-Rico C; Fariñas MC; Rodrigo E; Loeches B; López-Oliva MO; Montejo M; Lauzurica R; Horcajada JP; Pascual J; Andrés A; Aguado JM;
    Am J Transplant; 2020 Feb; 20(2):451-462. PubMed ID: 31550408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Fosfomycin for Complicated or Multidrug-Resistant Urinary Tract Infections: Patient Characteristics and Outcomes.
    Giancola SE; Mahoney MV; Hogan MD; Raux BR; McCoy C; Hirsch EB
    Chemotherapy; 2017; 62(2):100-104. PubMed ID: 27788499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and intravenous fosfomycin in complicated urinary tract infections.
    López-Montesinos I; Horcajada JP
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):37-44. PubMed ID: 31131591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosfomycin tromethamine for the Treatment of Cystitis in Abdominal Solid Organ Transplant Recipients With Renal Dysfunction.
    Kerstenetzky L; Jorgenson MR; Descourouez JL; Leverson G; Rose WE; Redfield RR; Smith JA
    Ann Pharmacother; 2017 Sep; 51(9):751-756. PubMed ID: 28511545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficiency of fosfomycin trometamol for treatment of acute uncomplicated cystitis].
    Kuzmenko AV; Kuzmenko VV; Gyaurgiev TA
    Urologiia; 2018 Dec; (6):70-75. PubMed ID: 30742381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rationale for the choice of an antibiotic for urinary tract infections with an emphasis on the environmental safety of therapy].
    Yakovlev SV; Suvorova MP
    Urologiia; 2021 Sep; (4):97-105. PubMed ID: 34486282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of single-dose fosfomycin tromethamine and other antibiotics for lower uncomplicated urinary tract infection in women and asymptomatic bacteriuria in pregnant women: A systematic review and meta-analysis.
    Wang T; Wu G; Wang J; Cui Y; Ma J; Zhu Z; Qiu J; Wu J
    Int J Antimicrob Agents; 2020 Jul; 56(1):106018. PubMed ID: 32417205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase Escherichia coli urinary tract infection treatment.
    Deemer K; Grey J; Fronczek C; Marr K
    Am J Health Syst Pharm; 2020 Nov; 77(Supplement_4):S105-S110. PubMed ID: 32840305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fosfomycin for treatment of uncomplicated lower urinary tract infection].
    Al-Shukri SH; Slesarevskaya MN; Kuzmin IV
    Urologiia; 2018 Dec; (5):153-158. PubMed ID: 30575367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.